UR Cardiology Chief Accepts Appointment as Study Section Chair
June 17, 1999
Bradford C. Berk, M.D., Ph.D., chief of Cardiology at the University of Rochester Medical Center and director of the Center for Cardiovascular Research, a component of the Aab Institute of Biomedical Sciences, has accepted an invitation by the National Institutes of Health to serve as chair of the Experimental Cardiovascular Sciences Study Section, Center for Scientific Review.
A nationally recognized expert on the molecular biology and genetics of cardiovascular disease, Berk was selected on the basis of demonstrated competence and achievement in his scientific discipline as evidenced by the quality of his research accomplishments, publications in scientific journals, and other significant achievements.
As chair of the Experimental Cardiovascular Sciences Study Section from July 1, 1999, to June 30, 2000, Berk will direct 20 cardiovascular experts in evaluating grant applications submitted to the National Institutes of Health.
Berk’s current NIH-funded research includes studies on: the role of sodium in high blood pressure; the mechanisms that make blood vessels sense changes in blood flow; how oxidative stress promotes inadequate circulation, causing ischemic heart disease, and conversely, how antioxidants such as vitamins E and C protect the vessel. He is also studying hormones such as angiotensin II and nitric oxide that regulate both the structure and function of blood vessels. Additionally, he is studying genetic influences on the structure of blood vessels.
Prior to coming to the University of Rochester last fall, Berk was director of both Cardiovascular Research and the Cardiovascular Fellowship Training Program at the University of Washington in Seattle.
Berk earned his undergraduate degree from Amherst College, and his medical and Ph.D. degrees from the University of Rochester School of Medicine and Dentistry. He completed his medical residency at Brigham and Women’s Hospital in Boston.